Adolescent Cannabis Vaping Trends (2021–2023): Delta-9-Tetrahydrocannabinol, Cannabidiol, and Synthetic Cannabinoids
Open Access
- 2 July 2025
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (6) , 107655
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (GNT1176137, GNT2026806)
- University of Queensland
This publication has 48 references indexed in Scilit:
- Adolescent Δ8-THC and Marijuana Use in the USJAMA, 2024
- Prevalence and Factors Associated With Vaping Cannabidiol Among US AdolescentsJAMA Network Open, 2023
- Vaping of Cannabis, Cannabidiol, and Synthetic Cannabis Among US Sexual Minority YouthsJAMA Network Open, 2023
- Prevalence and self-reported reasons of cannabis use for medical purposes in USA and CanadaPsychopharmacology, 2022
- Prevalence of Adolescent Cannabis VapingJAMA Pediatrics, 2021
- Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonistsArchives of Pharmacal Research, 2021
- Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung InjuryJournal of Medical Toxicology, 2020
- Self-reported Marijuana Use in Electronic Cigarettes Among US Youth, 2017 to 2018JAMA, 2020
- Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use CannabisJAMA Network Open, 2018
- The adverse health effects of chronic cannabis useDrug Testing and Analysis, 2013